assetIcon

Vertex Pharmaceuticals Incorporated (VRTX) Stock Price Today

Overview

Financial

Technicals

Analysis

Corporate Action

About

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.


Technical Indicators

|

|

|

Overall Summary

Bearish (17)

Neutral (2)

Bullish (8)


Performance

VRTX ROI

arrow
+16.27%

% from 52W High

-5.95%
$486

52W Low: $392.81

30 Apr 2024

52W High: $516.74

08 Nov 2024


Key Stats

Market Cap
Market Cap
$124.50B
Sector
Sector
Health
3M Drawdown
3M Drawdown
-7.21%
Enterprise Value
Enterprise Value
$120.13B
Dividend Yield
Dividend Yield
-
Trading Activity
Trading Activity
96% Buy
|
4% Sell
Typical Hold Time
Typical Hold Time
55 days

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions



Let’s trade or invest in this asset by signing up or logging in!

register_card

Let’s trade or invest in this asset by signing up or logging in!

You can also download our app!

item
item
item